Use of Myoinositol in Polycystic Ovary Syndrome

    September 2025 in “ Obstetrics and gynecology. ”
    Shadab Salehpour, Sedighe Hosseini, Zahra Zarisfi
    Studysummary This review examines the pathophysiology of PCOS and reports that myoinositol may improve menstrual regularity, insulin sensitivity, and reproductive outcomes, with comparable efficacy to metformin and often better tolerability.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on intechopen.com →
    Discuss this study in the Community →

    Research cited in this study 13

    1. The Effect of Vitamin D on the Hormonal Profile of Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis Middle East Fertility Society Journal · 2024
    2. Polycystic Ovary Syndrome Nature Reviews Disease Primers · 2024
    3. Update on the Combination of Myo-Inositol/D-Chiro-Inositol for the Treatment of Polycystic Ovary Syndrome Gynecological Endocrinology · 2024
    4. Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism · 2023
    5. Comparing the Efficacy of Myo-Inositol Plus Alpha-Lactalbumin Versus Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome Metabolites · 2023
    6. Current Guidelines for Diagnosing Polycystic Ovary Syndrome Diagnostics · 2023
    7. An Update of Polycystic Ovary Syndrome: Causes and Therapeutic Options Heliyon · 2022
    8. Insulin Resistance and Elevated Androgen Levels: A Major Cause of Polycystic Ovary Syndrome Frontiers in Endocrinology · 2021
    9. Cutaneous Manifestations of Polycystic Ovary Syndrome Dermatology Reports · 2021
    10. Sex Hormone-Binding Globulin as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome International Journal of Molecular Sciences · 2020
    11. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies Clinical medicine insights · 2019
    12. Potential Role and Therapeutic Interests of Myo-Inositol in Metabolic Diseases Biochimie · 2013
    13. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS) Human Reproduction · 2003